Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase 3 3Phase EARLY_PHASE1 2Phase 4 2Phase NA 1

Status

Withdrawn 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1Gynecologic 1Endocrine 1

Conditions

Neoplasms 2Sarcoma 1Pituitary Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Pafolacianine × Clear all
NCT06235125 2026-06-05

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting
10 enrolled
Sarcoma

Sarcoma, Osteosarcoma

NCT02602119 2022-06-28

Intraoperative Imaging of Pulmonary Nodules by OTL38

University of Pennsylvania

Phase 1 Completed
262 enrolled
Tumor-Agnostic

Neoplasms

NCT04941378 2022-06-27

OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer

Abramson Cancer Center at Penn Medicine

Phase 1 Withdrawn
Gynecologic

Ovarian Neoplasms

NCT02629549 2019-08-06

Intraoperative Imaging of Pituitary Adenomas by OTL

University of Pennsylvania

Phase 1 Terminated
33 enrolled
Endocrine

Neoplasms, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡